Published in Lancet on October 25, 2004
Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol (2007) 2.26
What is the optimal management of dysphagia in metastatic esophageal cancer? Curr Oncol (2012) 1.57
Fully covered self-expandable metal stents (SEMS), partially covered SEMS and self-expandable plastic stents for the treatment of benign esophageal ruptures and anastomotic leaks. BMC Gastroenterol (2012) 1.50
Oesophageal cancer--an overview. Nat Rev Gastroenterol Hepatol (2013) 1.18
Esophageal stenting in the setting of malignancy. ISRN Gastroenterol (2011) 1.01
Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study. Surg Endosc (2010) 1.01
Evaluation design of a reactivation care program to prevent functional loss in hospitalised elderly: a cohort study including a randomised controlled trial. BMC Geriatr (2011) 0.98
The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes. Dig Dis Sci (2010) 0.97
Re-organisation of oesophago-gastric cancer care in England: progress and remaining challenges. BMC Health Serv Res (2009) 0.94
Endoscopic stenting: where are we now and where can we go? World J Gastroenterol (2008) 0.85
Combined brachytherapy and external beam radiation: an effective approach for palliation in esophageal cancer. J Contemp Brachytherapy (2015) 0.85
Radiotherapy versus stenting in treating malignant dysphagia. J Gastrointest Oncol (2012) 0.83
Recent Advances in Gastrointestinal Stent Development. Clin Endosc (2015) 0.83
Intraluminal brachytherapy in oesophageal cancer: defining its role and introducing the technique. J Contemp Brachytherapy (2014) 0.83
Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer. Viszeralmedizin (2015) 0.82
Role of stenting in gastrointestinal benign and malignant diseases. World J Gastrointest Endosc (2015) 0.82
Stenting as a palliative method in the management of advanced squamous cell carcinoma of the oesophagus and gastro-oesophageal junction. Wideochir Inne Tech Maloinwazyjne (2016) 0.81
The evaluation of esophageal stenting complications in palliative treatment of dysphagia related to esophageal cancer. Med Sci Monit (2012) 0.81
The safety and usefulness of neutron brachytherapy and external beam radiation in the treatment of patients with gastroesophageal junction adenocarcinoma with or without chemotherapy. Radiat Oncol (2014) 0.80
Palliative Endoscopic Therapy of Esophageal Cancer. Viszeralmedizin (2015) 0.80
Management of localized esophageal cancer in the older patient. Oncologist (2014) 0.79
Antireflux versus conventional self-expanding metallic Stents (SEMS) for distal esophageal cancer: results of a multicenter randomized trial. Endosc Int Open (2016) 0.79
Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer (2008) 0.79
Early pain detection and management after esophageal metal stent placement in incurable cancer patients: A prospective observational cohort study. Endosc Int Open (2016) 0.78
Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature. Cancer Metastasis Rev (2016) 0.78
Clinical trials of interventional oncology-moving from efficacy to outcomes. Nat Rev Clin Oncol (2014) 0.78
Radiological image-guided placement of covered Niti-S stent for palliation of dysphagia in patients with cervical esophageal cancer. Dysphagia (2013) 0.78
Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer (2004) 0.77
Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges. BMC Res Notes (2014) 0.77
Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer. Cancer Res Treat (2015) 0.77
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature. Oncol Lett (2014) 0.77
Palliative radiotherapy in esophageal cancer. Indian J Surg (2013) 0.76
Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma. World J Surg Oncol (2016) 0.76
Randomized controlled trial to investigate the effect of metal clips on early migration during stent implantation for malignant esophageal stricture. Can J Surg (2015) 0.75
Palliative enteral feeding for patients with malignant esophageal obstruction: a retrospective study. BMC Palliat Care (2015) 0.75
Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia. Oncol Lett (2015) 0.75
[Curietherapy in the palliative treatment of esophageal cancer]. Pan Afr Med J (2015) 0.75
High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced esophageal cancer: preliminary results. J Contemp Brachytherapy (2017) 0.75
Unintentional Long-Term Esophageal Stenting due to a Complete Response in a Patient with Stage UICC IV Adenocarcinoma of the Gastroesophageal Junction. Case Rep Gastroenterol (2016) 0.75
Endoscopic palliation of advanced esophageal cancer. J Med Life (2015) 0.75
Self-Expandable Metallic Stent Placement for the Palliation of Esophageal Cancer. J Korean Med Sci (2017) 0.75
Palliation of malignant esophageal obstruction and fistulas with covered self expandable metallic stents: assessment of a simple fluroscopic method. Int J Clin Exp Med (2015) 0.75
Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer. United European Gastroenterol J (2016) 0.75
Small caliber covered self-expanding metal stents in the management of malignant dysphagia. J Gastrointest Oncol (2016) 0.75
New era of electronic brachytherapy. World J Radiol (2017) 0.75
Cost-effectiveness of palliation of unresectable esophageal cancer. Dig Dis Sci (2008) 0.75
Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis. PLoS One (2017) 0.75
A decade of day-case endoscopically guided stent placement in malignant oesophagogastric strictures. Surg Endosc (2016) 0.75
[Endoscopic palliation of esophageal and bronchial carcinomas]. Internist (Berl) (2010) 0.75
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol (2003) 7.57
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology (2011) 6.36
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med (2010) 6.36
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol (2014) 4.59
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology (2013) 4.58
Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med (2006) 4.48
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 4.11
Management in patients with liver cirrhosis and an umbilical hernia. Surgery (2007) 4.09
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol (2008) 3.94
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst (2003) 3.67
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 3.66
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst (2007) 3.55
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
A prospective study comparing video capsule endoscopy with double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol (2006) 3.27
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology (2009) 3.20
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
Competence measurement during colonoscopy training: the use of self-assessment of performance measures. Am J Gastroenterol (2012) 3.17
Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15
Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15
A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J (2011) 3.14
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 3.10
Imputation is beneficial for handling missing data in predictive models. J Clin Epidemiol (2007) 3.08
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med (2012) 3.05
Total extraperitoneal inguinal hernia repair compared with Lichtenstein (the LEVEL-Trial): a randomized controlled trial. Ann Surg (2010) 3.02
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med (2014) 3.00
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A (2013) 2.99
Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery (2005) 2.97
Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med (2010) 2.82
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst (2010) 2.79
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg (2007) 2.78
Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol (2004) 2.77
A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol (2007) 2.73
Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA (2006) 2.73
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet (2005) 2.71
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2007) 2.68
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma (2007) 2.57
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut (2011) 2.57
End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study. Ann Surg (2011) 2.56
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst (2009) 2.55
Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma (2007) 2.54
Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg (2003) 2.51
Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol (2010) 2.50
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J (2012) 2.43
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol (2009) 2.42
Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (2005) 2.42
Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP). Anesth Analg (2002) 2.41
Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology (2008) 2.41
Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc (2010) 2.38
Reclassification calculations for persons with incomplete follow-up. Ann Intern Med (2010) 2.35
The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med (2007) 2.34
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ (2013) 2.31
Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol (2010) 2.29
Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med (2007) 2.26
Reporting and methods in clinical prediction research: a systematic review. PLoS Med (2012) 2.26
Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol (2007) 2.26
Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol (2011) 2.24
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med (2013) 2.23
Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc (2009) 2.23
Chronic gastrointestinal ischaemia: shifting paradigms. Gut (2010) 2.23
Safety of endoscopic removal of self-expandable stents after treatment of benign esophageal diseases. Gastrointest Endosc (2013) 2.22
Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis. Liver Transpl (2005) 2.21
Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study. Am J Epidemiol (2012) 2.20
In vitro evaluation of the radial and axial force of self-expanding esophageal stents. Endoscopy (2013) 2.18
Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest Endosc (2007) 2.18
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment? Crit Care Med (2009) 2.16
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC. Int J Cancer (2010) 2.15
Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med (2013) 2.13
Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials. J Neurosurg (2002) 2.12
Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med (2007) 2.12
Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc (2006) 2.10
IMPACT database of traumatic brain injury: design and description. J Neurotrauma (2007) 2.10
Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest Endosc (2011) 2.09
Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg (2011) 2.08
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology (2002) 2.06
High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut (2011) 2.06